Skip to main content

Table 2 Number of patients using potential inappropriate medications before and after medication review. (n = 1720 patients)

From: Effects of medication reviews on use of potentially inappropriate medications in elderly patients; a cross-sectional study in Swedish primary care

 

Before medication review

After medication review

p-valuea

Total

Nursing home

Home care

Total

Nursing home

Home care

Patients with antipsychotics, n (%)

194 (11.3)

184 (12.2)

10 (4.7)

136 (7.9)

128 (8.5)

8 (3.8)

< 0.001

Patients with anticholinergics, n (%)

158 (9.2)

139 (9.2)

19 (9.0)

72 (4.2)

60 (4.0)

12 (5.7)

< 0.001

Patients with propiomazine, n (%)

43 (2.5)

33 (2.2)

10 (4.7)

16 (0.9)

10 (0.7)

6 (2.8)

< 0.001

Patients with tramadol, n (%)

90 (5.2)

81 (5.2)

9 (4.2)

41 (2.4)

39 (2.6)

2 (0.9)

< 0.001

Patients with long-acting benzodiazepines, n (%)

112 (6.5)

90 (6.0)

22 (10.4)

62 (3.6)

51 (3.4)

11 (5.2)

0.001

Patients with ≥1 PIMb, n (%)

510 (29.7)

453 (30.0)

57 (26.9)

299 (17.4)

266 (17.6)

33 (15.6)

< 0.001

Patients with ≥3 psychotropics, n (%)

395 (23.0)

367 (24.3)

28 (13.2)

296 (17.2)

274 (18.2)

22 (10.4)

< 0.001

  1. bPIM Potentially Inappropriate Medication (antipsychotics, anticholinergics, propiomazine, tramadol and long-acting benzodiazepines)
  2. aChi square test between total numbers (nursing home and home care together)